Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check?
about
Systematic review of clinical practice guidelines recommendations about primary cardiovascular disease prevention for older adultsFactors influencing general practitioners' decisions about cardiovascular disease risk reassessment: findings from experimental and interview studies.Overview of guidelines for the management of dyslipidemia: EU perspectivesRisk Factors for Cardiovascular Disease and Their Clustering among Adults in Jilin (China)Personalized prediction of lifetime benefits with statin therapy for asymptomatic individuals: a modeling studyA systematic review of recent clinical practice guidelines on the diagnosis, assessment and management of hypertensionPlatelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*Low vitamin D status and obesity: Role of nutritionist.General practitioners' use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study.I don't believe it, but i'd better do something about it: patient experiences of online heart age risk calculators.Communicating cardiovascular disease risk: an interview study of General Practitioners' use of absolute risk within tailored communication strategies.Comparative effectiveness of guidelines for the management of hyperlipidemia and hypertension for type 2 diabetes patients.Development and pilot of an internationally standardized measure of cardiovascular risk management in European primary care.Cardiovascular disease by diabetes status in five ethnic minority groups compared to ethnic Norwegians.Short-term diet and moderate exercise in young overweight men modulate cardiocyte and hepatocarcinoma survival by oxidative stress.Pathogenic mechanisms shared between psoriasis and cardiovascular diseasePredictors of health-related quality of life in patients at risk for cardiovascular disease in European primary care.Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies.Effect of including nonfatal events in cardiovascular risk estimation, illustrated with data from The Netherlands.Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study.Identifying factors associated with experiences of coronary heart disease patients receiving structured chronic care and counselling in European primary care.Cardiovascular Disease Population Risk Tool (CVDPoRT): predictive algorithm for assessing CVD risk in the community setting. A study protocol.Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies.Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in AsiaCardiovascular risk scores do not account for the effect of treatment: a review.A multifaceted quality improvement intervention for CVD risk management in Australian primary healthcare: a protocol for a process evaluationImpact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton.Predictive value of updating Framingham risk scores with novel risk markers in the U.S. general population.Systematic review of evidence-based guidelines on medication therapy for upper respiratory tract infection in children with AGREE instrumentThe Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes MellitusPredicting Stroke Risk Based on Health Behaviours: Development of the Stroke Population Risk Tool (SPoRT)Addressing the management of atrial fibrillation - a systematic review of the role of dronedarone.Relationship of inflammation and endothelial dysfunction with risks to cardiovascular disease among people in Inner Mongolia of China.Which interventions offer best value for money in primary prevention of cardiovascular disease?Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk.A Community-based Cross-sectional Study of Cardiovascular Risk in a Rural Community of Puducherry.Evidence review and clinical guidance for the use of ziprasidone in Canada.Myocardial perfusion imaging in patients with a recent, normal exercise test.Which one is more important, obesity or cardio metabolic risk factors?Ability of body mass index to predict abnormal waist circumference: receiving operating characteristics analysis.
P2860
Q26796403-542E3E31-3057-4708-8214-0E48E800999FQ27313674-A1E58DE7-CA2A-4CEB-B1BA-50D62EDCFD99Q28069411-1638E213-9B72-49A2-AD82-07E1F3DEF049Q28385189-71D60C6C-558B-4241-88B8-7A4188D97A74Q28484624-9B8932E4-6A11-48F4-AE93-B2C1B0D3EE29Q28485176-F103A237-DC77-416C-9800-895D7376E0DFQ28743899-D5D7B1CB-15D0-400E-8473-EB409934A8A1Q30235602-E6FD5415-AB86-4366-B17B-D496E93DC519Q33629449-03F2C58E-AB89-4D8D-947C-91712EEB48ADQ33633369-EE14914D-ADEF-44AF-97C3-A5BA60CEA6CAQ33701669-79C5C7C7-4D2A-4A37-AC82-4CEAFAE63D96Q33808664-29C064BD-E674-445A-8953-A6E8D1E69C6AQ33865199-7E666240-0C98-4F75-8380-C3B2208FF284Q33959814-17504383-1B6B-48D4-8319-429CC77D7430Q34100693-C919EC69-2C5D-41D3-853A-A6922CD1D3ABQ34107573-B2C8B7F6-89DF-4838-9627-51430761AF74Q34117492-0E65F3D0-E9B2-4769-8C98-2C275C10B0F1Q34170210-27C7F2FE-86D2-4792-8C88-BBFC516FC0F6Q34207158-C7296291-7D09-425C-93E7-5F176D034E49Q34289448-C9530B60-C8BF-418B-AB7B-C39FA82D0E04Q34353957-3A4C1C7E-9DCD-4705-8D94-443DFDA2BE19Q34397159-D6C11EEC-97CF-49F8-913B-0DE53D6D9509Q34631709-B0B76D1F-C9B7-4CAC-BD1B-051DA1578048Q34756253-665DF7AF-7B0E-482A-91F4-3DF016C7ADEFQ34769415-2219718D-4A14-41E9-A824-C2DBF78F382AQ34788667-25D421CA-8DF8-4C45-8FC1-949EE9B9095BQ35092371-554B180D-50CC-4CCB-B261-37486D7C4474Q35099546-88030D50-784D-4795-BC19-932653E6EC02Q35105961-4F5CDE55-19DC-469E-A850-5CAA8C64745EQ35730973-B9ABE84B-A77D-413D-A37E-5BB85AFA81C5Q35861221-5C3C655E-31D6-401E-AD89-0848119E4EA9Q36026806-CD142095-5F0F-4FBC-A9B1-E4B62B97217FQ36059027-77F11E95-06BD-45F1-ADDD-2C163B42A730Q36109666-5A3E4D78-488A-4277-A1B7-3CA3F11AC0B3Q36475652-E578BD44-B001-47DD-8456-D321B0E257D0Q36536944-526816A9-F783-4F79-AC89-A698E8509BD7Q36588607-266425F7-F46E-4230-93E9-878B3EADB9EFQ36722107-CFC7E38E-8821-4953-90FC-3A373E17B288Q36957450-7FA2095B-74AF-436C-A547-DE860C4169C0Q37568838-F869FFE1-4AE3-45CF-BC8D-CA3FB49B708C
P2860
Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check?
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Systematic review of guideline ...... a cardiovascular health check?
@ast
Systematic review of guideline ...... a cardiovascular health check?
@en
Systematic review of guideline ...... a cardiovascular health check?
@nl
type
label
Systematic review of guideline ...... a cardiovascular health check?
@ast
Systematic review of guideline ...... a cardiovascular health check?
@en
Systematic review of guideline ...... a cardiovascular health check?
@nl
altLabel
Systematic Review of Guidelines on Cardiovascular Risk Assessment
@en
prefLabel
Systematic review of guideline ...... a cardiovascular health check?
@ast
Systematic review of guideline ...... a cardiovascular health check?
@en
Systematic review of guideline ...... a cardiovascular health check?
@nl
P2093
P1476
Systematic review of guideline ...... a cardiovascular health check?
@en
P2093
Ersen B Colkesen
Jacob J Visser
M G Myriam Hunink
Roderik A Kraaijenhagen
Sandra Spronk
P356
10.1001/ARCHINTERNMED.2009.434
P407
P577
2010-01-01T00:00:00Z